Skip to content
10-Q

Quarterly Report

CG Oncology, Inc. CGON

0001193125-25-283000

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 80.67M sh
Shares Diluted Q3 2025 · Sep 30, 2025 76.73M sh
Shares Diluted Q3 2025 · Sep 30, 2025 76.38M sh
Shares Diluted Q3 2025 · Sep 30, 2024 67.14M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.31M sh
Capex Q3 2025 · Sep 30, 2025 $127K
Capex Q3 2025 · Sep 30, 2024 $25K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$96.13M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$58.05M
Long Term Debt Q3 2025 · Sep 30, 2025 $3M
Long Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $45.15M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $257.07M
Stockholders Equity Q3 2025 · Sep 30, 2025 $687.64M
Stockholders Equity Q3 2025 · Jun 30, 2025 $670.36M
Stockholders Equity Q3 2025 · Mar 31, 2025 $704.76M
Stockholders Equity Q3 2025 · Dec 31, 2024 $733.38M
Stockholders Equity Q3 2025 · Sep 30, 2024 $536.77M
Stockholders Equity Q3 2025 · Jun 30, 2024 $552.36M
Stockholders Equity Q3 2025 · Mar 31, 2024 $568.94M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$123.1M
Current Liabilities Q3 2025 · Sep 30, 2025 $30.53M
Current Liabilities Q3 2025 · Dec 31, 2024 $21.37M
Total Liabilities Q3 2025 · Sep 30, 2025 $42.27M
Total Liabilities Q3 2025 · Dec 31, 2024 $21.42M
Current Assets Q3 2025 · Sep 30, 2025 $695.79M
Current Assets Q3 2025 · Dec 31, 2024 $754.21M
Total Assets Q3 2025 · Sep 30, 2025 $729.91M
Total Assets Q3 2025 · Dec 31, 2024 $754.8M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.57
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.57
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.93
Eps Basic Q3 2025 · Sep 30, 2025 −$0.57
Eps Basic Q3 2025 · Sep 30, 2025 −$1.57
Eps Basic Q3 2025 · Sep 30, 2024 −$0.30
Eps Basic Q3 2025 · Sep 30, 2024 −$0.93
Sga Expense Q3 2025 · Sep 30, 2025 $23.33M
Sga Expense Q3 2025 · Sep 30, 2025 $55.53M
Sga Expense Q3 2025 · Sep 30, 2024 $8.72M
Sga Expense Q3 2025 · Sep 30, 2024 $22M
Rd Expense Q3 2025 · Sep 30, 2025 $27.88M
Rd Expense Q3 2025 · Sep 30, 2025 $86.68M
Rd Expense Q3 2025 · Sep 30, 2024 $19.62M
Rd Expense Q3 2025 · Sep 30, 2024 $55.3M
Net Income Q3 2025 · Sep 30, 2025 −$43.81M
Net Income Q3 2025 · Sep 30, 2025 −$119.69M
Net Income Q3 2025 · Jun 30, 2025 −$41.43M
Net Income Q3 2025 · Mar 31, 2025 −$34.45M
Net Income Q3 2025 · Sep 30, 2024 −$20.41M
Net Income Q3 2025 · Sep 30, 2024 −$56.24M
Net Income Q3 2025 · Jun 30, 2024 −$18.9M
Net Income Q3 2025 · Mar 31, 2024 −$16.93M
Operating Income Q3 2025 · Sep 30, 2025 −$51.13M
Operating Income Q3 2025 · Sep 30, 2025 −$142.07M
Operating Income Q3 2025 · Sep 30, 2024 −$28.3M
Operating Income Q3 2025 · Sep 30, 2024 −$76.62M
Revenue Q3 2025 · Sep 30, 2025 $1.67M
Revenue Q3 2025 · Sep 30, 2025 $1.72M
Revenue Q3 2025 · Sep 30, 2024 $43K
Revenue Q3 2025 · Sep 30, 2024 $683K